RTM is the reimbursable workflow that runs alongside antidepressant and anxiolytic care between your visits, whether that's a month or a quarter. FDA-registered software collects therapeutic data (adherence, symptom curve, side-effect timeline, behavioral skill use) and delivers a 60-second CBT or MET nudge matched to the moment. You walk into the next visit with a documented arc instead of a mystery.
The order defines the scope. RTM documents and informs over the cycle. It does not alert, and it does not create a monitoring duty you didn't order.
30-second walkthrough. Pause anytime.
Personalized CBT and MET microlearning isn't a tagline - it's a delivery system. Three pieces that work together.
Six methods illustrated below. The full library carries more.
Plus thought records, behavioral experiments, graduated exposure, problem-solving therapy, values clarification, normalization protocols, and more.
Every micro-lesson is derived from CBT and MET best practices and edited by licensed behavioral health professionals before it ever reaches a patient.
Delivered across formats (video, animation, and text) with tone, length, and reading level tuned to the patient. The library evolves with each patient as engagement signals reveal what lands.
Live auxiliary personnel (clinical staff who perform interactive reviews and, when desired, interactive communication with the patient under your general supervision) is available as a higher-tier service.
Software routes each patient across methods, formats, tone, and length based on response and engagement signals. Your clinical team reviews routing and adjusts when patterns don't stick. Algorithmic matching makes it scale. Clinical judgment makes it work.
The patient never sees the machinery. She sees a clinician answering the moments she's in, over weeks. You walk into the next visit with a documented arc instead of a mystery.
Up to half of antidepressant patients stop or alter their regimen within the first 90 days, often without telling anyone. You find out at the next visit, if at all. RTM surfaces it in the cycle.
Weeks 1–4 of titration carry the highest activation-symptom risk, especially in adolescents. RTM documents the pattern in the window you're most worried about.
Sexual, GI, sleep, and emotional-blunting side effects are systematically under-reported in-visit. A private daily log surfaces them in summary form before the visit.
The work is already happening between your visits. RTM makes it visible, billable, and clinically useful.
Skips her SSRI on good days. Doubles on bad ones. Thinks she's saving doses for when she really needs them.
Gets a 60-second MET decisional-balance prompt: why today's dose matters even when yesterday felt fine.
Three weeks into a new antidepressant. Sexual side effects she won't mention at her 12-minute appointment.
Gets a normalization micro-lesson and a private side-effect log she can share at the visit.
Adolescent two weeks into an SSRI. Parent thinks it's not working yet and is considering stopping the medication.
Parent gets a 90-second MI-informed nudge (change-talk elicitation from a clinician on video) about what week-two means in titration and the activation window to watch.
If you're the patient's only clinician, that's you, and RTM is additive. If there's a care team, you decide together who owns it. Everyone else still sees the data.
A prescriber might be the patient's only clinician, might provide therapy and medication management both, or might share the patient with a separate therapist. The rule is the same in every case: one clinician of record bills RTM per 30-day episode. Here's how that resolves.
The order defines the scope. RTM documents and informs over the cycle, for the one clinician of record. It does not create a second clinical obligation for anyone who isn't billing.
Nudge RTM is an FDA-registered Class I device. It is not a Class II decision-support or alerting device. It captures and organizes therapeutic data so the pattern is visible at your next visit. The clinical decisions stay yours.
RTM also has codes for respiratory (98976) and musculoskeletal (98977) device supply. Not applicable to behavioral health.
Policy summary, billing math, eligibility checklist. No follow-up calls unless you ask.
We'll add you to one quarterly RTM-policy update email. Unsubscribe in one click.